Delivery Order DJB10907BPA08030-DJBLEXHB210940

This federal contract award is for the delivery of apheresis platelets (A-PLT) 250ML to support U.S. military medical facilities in South Korea. The contract is a Blanket Purchase Agreement (BPA) call with a firm-fixed-price (FFP) pricing type, awarded to the Republic of Korea National Red Cross, doing business as Gyeonggi Blood Center Red Cross, a non-profit organization. The award has a ceiling value of $2,475.28 and an ultimate completion date of September 30, 2024. The contract was awarded...

The Defense Health Agency awarded Octapharma USA Inc. a delivery order on September 16, 2025, to supply 1,600 units of Octaplas LG kits with a ceiling value of $1.6 million. The contract is priced on a firm fixed-price basis with an ultimate completion date of January 16, 2026, and will be performed at Travis Air Force Base in Fairfield, California. No small business set-aside was utilized for this procurement. Octaplas LG is a liquid plasma product used for transfusion in medical settings to...

This federal contract award, valued at $3,754.68, was issued by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense, to Fenwal, Inc., a subsidiary of Fresenius Kabi. Fenwal is a global blood technology company that specializes in the development and manufacture of products and services for blood collection, separation, storage, and transfusion. The contract is for the delivery of a plasma extractor, which is a critical piece of equipment used in...

This firm fixed-price contract was awarded by the Defense Health Agency to Terumo BCT Inc., a manufacturer of blood management products and services. The contract has a potential value of $241,866.00 and includes the supply of therapeutic plasma exchange (TPE) sets, red blood cell (RBC) exchange sets, TRIMA ACCEL RBC/Platelet/Plasma sets, and other similar items. The contract is a blanket purchase agreement (BPA) call, which suggests it is part of a larger indefinite delivery/indefinite quantity...

The U.S. Defense Health Agency awarded a firm-fixed-price contract to The Republic Of Korea National Red Cross, doing business as Gyeonggi Blood Center Red Cross, a non-profit organization, to provide apheresis platelets and other blood products in support of military healthcare operations in South Korea. The potential value of this contract is $11,528.34, with a completion date of September 30, 2023. The contract was issued as a Blanket Purchase Agreement (BPA) call, which is part of a larger...

The Defense Health Agency issued a purchase order to Cerus Corporation for CERUS INTERCEPT Platelet Processing Sets on October 1, 2025, with a ceiling value of $367,100. Performance is located in Concord, California, and the order extends through September 30, 2030. The procurement, structured as firm fixed-price, originated from a sources sought notice posted by Tripler Army Medical Center in June 2025 to assess market capabilities for specialized blood processing equipment. The INTERCEPT Blood...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Werfen USA LLC for a platelet reactivity testing system valued at $25,343.81 on March 10, 2021, with completion on April 10, 2021. The order is firm fixed price with no set-aside. Work is performed in Bedford, Massachusetts, where Werfen manufactures in vitro diagnostic equipment and clinical laboratory instrumentation.</p>

This is a federal purchase order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi, for the supply of various blood collection and transfusion-related products and services. The contract, valued at $4,594.60, has an ultimate completion date of October 22, 2024. Fenwal, a global blood technology company, has been a registered vendor with the U.S. federal government since 2007 and has established itself as a key supplier to...

The Defense Logistics Agency Troop Support Medical awarded a firm fixed price purchase order valued at approximately $989 to Fenwal, Inc. for blood transfer sets. The contract has a period of performance from September 29 through October 4, 2023, with all work to be conducted in Lake Zurich, Illinois. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports Department of Defense health care programs by procuring medical supplies and equipment for troops....

The Defense Health Agency awarded a $104,256 firm fixed-price purchase order to Cerus Corporation on September 30, 2019, for INTERCEPT Platelet Small Volume Sets, with performance through September 3, 2024. The contract was awarded without a set-aside designation to Cerus Corporation, a Concord, California-based biomedical products manufacturer specializing in blood safety technologies. Cerus's INTERCEPT Blood System uses riboflavin and ultraviolet light technology to inactivate pathogens in...